Table 2.
Cell Line | Drugs | Combination index (CI) at the IC 50 |
---|---|---|
SK-UT-1 | ||
Gemcitabine:Docetaxel | 0.59 | |
Gemcitabine + Docetaxel + Dasatinib | 0.46 | |
Dasatinib- > Gemcitabine + Docetaxel | 1.77 | |
Gemcitabine + Docetaxel- > Dasatinib | 1.14 | |
Dasatinib + Gemcitabine- > Docetaxel | 1.32 | |
Dasatinib + Docetaxel- > Gemcitabine | 1.07 | |
Gemcitabine- > Docetaxel + Dasatinib | 1.8 | |
Docetaxel- > Gemcitabine + Dasatinib | N/D | |
SK-UT-1B | ||
Gemcitabine:Docetaxel | 1.36 | |
Gemcitabine + Docetaxel + Dasatinib | 1.4 | |
Dasatinib- > Gemcitabine + Docetaxel | 0.9 | |
Gemcitabine + Docetaxel- > Dasatinib | 1.36 | |
Dasatinib + Gemcitabine- > Docetaxel | 1.21 | |
Dasatinib + Docetaxel- > Gemcitabine | 1.0 | |
Gemcitabine- > Docetaxel + Dasatinib | 0.9 | |
Docetaxel- > Gemcitabine + Dasatinib | 1.5 |
Combination index scale: CI <0.9 synergistic, CI = 0.9-1.1 additive, CI = 1.1-1.2 slight antagonism,
CI = 1.2-1.45 moderate antagonism, CI = 1.45-3.3 antagonism, CI = 3.3-10 strong antagonism.
N/D = not determined.